DNA - Ginkgo Bioworks Holdings, Inc.
6.94
-0.010 -0.144%
Share volume: 1,335,179
Last Updated: 03-11-2025
Pharmaceutical Products/Biological Products, Except Diagnostic Substances:
0.00%
PREVIOUS CLOSE
CHG
CHG%
$6.95
-0.01
0.00%
Summary score
22%
Profitability
0%
Dept financing
13%
Liquidity
50%
Performance
40%
Sector
Manufacturing
Industry
Pharmaceutical Products/Biological Products, Except Diagnostic Substances
Long-term ratios 31-Dec-2020 - 31-Dec-2024
The data are presented for the financials results of the quarters of the last 4 years.
Return on equity
0%
Return on assets
-7.45%
Return on sales
-236.29%
Return on invested capital
0%
Total debt ratio
48.02%
Debt ratio change over timeo
0%
Current Ratio
5.62%
Quick Ratio
0%
Cash Position Ratio
5.24%
Short-term ratios 31-Dec-2023 - 31-Dec-2024
The data are presented for the financials results of the quarters of the last year.
Return on equity
0%
Return on assets
-7.45%
Return on sales
-236.29%
Return on invested capital
0%
Total debt ratio
48.02%
Debt ratio change over timeo
0%
Current Ratio
5.62%
Quick Ratio
0%
Cash Position Ratio
5.24%
Last quarter ratios 31-Dec-2024
The data are presented for the financials results of the last quarter.
Return on equity
0%
Return on assets
-7.45%
Return on sales
-236.29%
Return on invested capital
0%
Total debt ratio
48.02%
Debt ratio change over time
0%
Current Ratio
5.62%
Quick Ratio
0%
Cash Position Ratio
5.24%
Performance ratios (change over 4 years) 31-Dec-2020 - 31-Dec-2024
The data are presented for the change financials results of the quarter of the last 4 years.
Return on equity
0%
Return on assets
0%
Return on sales
0%
Return on invested capital
0%
Total debt ratio
0%
Debt ratio change over time
0%
Current Ratio
0%
Quick Ratio
0%
Cash Position Ratio
0%
Compare in sector
The following table compares the individual analyzes for the other top 3 stocks within the same industry.
| Long-term ratios | DNA | AMGN | GILD | BIIB |
|---|---|---|---|---|
| Return on equity | 0% | 18.63% | 4.21% | 3.82% |
| Return on assets | -7.45% | 3.07% | 3.15% | 2.36% |
| Return on sales | -236.29% | 30.43% | 28.87% | 24.63% |
| Return on invested capital | 0% | 5.33% | 2.16% | 3.93% |
| Profitability | 0% | 99% | 64% | 63% |
| Total debt ratio | 48.02% | 92.23% | 67.37% | 47.08% |
| Debt ratio change over time | 0% | 18.13% | 116.87% | 2.96% |
| Dept financing | 13% | 29% | 43% | 13% |
| Current Ratio | 5.62% | 1.32% | 1.23% | 1.9% |
| Quick Ratio | 0% | 0.95% | 1.08% | 1.22% |
| Cash Position Ratio | 5.24% | 0.47% | 0.47% | 0.44% |
| Liquididy | 50% | 32% | 25% | 39% |
| Short-term ratios | DNA | AMGN | GILD | BIIB |
|---|---|---|---|---|
| Return on equity | 0% | 0% | -23.78% | 3.13% |
| Return on assets | -7.45% | 2.13% | 1.4% | 2.16% |
| Return on sales | -236.29% | 21.39% | 10.21% | 24.36% |
| Return on invested capital | 0% | 0% | -14.26% | 2.94% |
| Profitability | 0% | 47% | 27% | 100% |
| Total debt ratio | 48.02% | 93.35% | 67.38% | 41.59% |
| Debt ratio change over time | 0% | 0% | 8.62% | 18.48% |
| Dept financing | 13% | 25% | 30% | 36% |
| Current Ratio | 5.62% | 1.32% | 1.23% | 1.9% |
| Quick Ratio | 0% | 0.95% | 1.08% | 1.22% |
| Cash Position Ratio | 5.24% | 0.47% | 0.47% | 0.44% |
| Liquididy | 50% | 28% | 30% | 36% |